Emmaus Medical
  • CEO Letters
  • Overview
    • Mission
    • Leadership
      • Management Team
      • Board of Directors
    • Corporate Compliance
    • Corporate Governance
  • Products
    • Endari
  • Pipeline
    • Research Publications
    • Diverticulosis
    • Cell Sheet Engineering
  • News
    • Press Releases
    • Media Contacts
    • Media Kit
  • Investors
  • Career
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Pre-merger Emmaus Life Science SEC Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Emmaus Life Sciences Submits Temporary License Application in Bahrain for Endari®

Nov 10, 2020 11:25am EST

FDA Approves Updated Label for Endari®

Nov 03, 2020 11:30am EST

Emmaus Life Sciences Announces the Sale of its Telcon RF Pharmaceutical Inc. Shares

Oct 14, 2020 11:20am EDT

Emmaus Life Sciences Announces Informational Stockholders Meeting

Sep 01, 2020 8:00am EDT

UPDATE - Emmaus Life Sciences Announces Submission of Marketing Authorization Application to the Saudi Food and Drug Authority

Aug 18, 2020 1:41pm EDT

Emmaus Life Sciences Announces Submission of Marketing Authorization Application to the Saudi Food and Drug Authority

Aug 18, 2020 8:00am EDT

Emmaus Life Sciences Reports Additional Positive Preliminary Results in Diverticulosis Pilot Trial

Aug 05, 2020 8:00am EDT

Emmaus Life Sciences Provides Additional Operational and OTC Markets Updates

Jul 31, 2020 8:00am EDT

Emmaus Life Sciences Receives Scientific Advice From the EMA Regarding Xyndari™

Jul 29, 2020 12:09pm EDT

Emmaus Life Sciences Accelerates Middle East and North Africa (MENA) Growth Strategy with Opening of its Dubai Office

Jul 23, 2020 1:14pm EDT
RSS
  • Prev
    • 1...
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • ...17
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    Emmaus Medical, Inc. Registered ® Emmaus Medical, Inc, Torrance, CA. All rights reserved.

    • Privacy
    • Terms of Use
    • Contact